Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9

Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9

US Patent 11220532 · Granted Jan 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective targeting of apoptosis proteins by structurally-stabilized and/or cyst2025
BCL-W polypeptides and mimetics for treating or preventing chemotherapy-induced 2025
Stapled intracellular-targeting antimicrobial peptides to treat infection2025
Visual representations of peptide sequences2025
Compositions, assays, and methods for direct modulation of fatty acid metabolism2025
Selective targeting of ubiquitin- and ubiquitin-like E1-activating enzymes by st2025
Selective targeting of ubiquitin- and ubiquitin-like E1-activating enzymes by st2025
Compositions and methods for inhibition of FOXP32025
Compositions and methods for inhibition of FOXP32025
Reagents for quantitative mass spectrometry2024
Reagents for quantitative mass spectrometry2024
Reagents for quantitative mass spectrometry2024